Showing results (61-70 of 78) with videos related to
Sort By:
Pageof 8
JACC. Heart Failure|March 14, 2021
Changes in Use of Left Ventricular Assist Devices as Bridge to Transplantation With New Heart Allocation PolicyClancy W Mullan, Fouad Chouairi, Sounok Sen, et al.Plos One|March 2, 2021
Impact of the new heart allocation policy on patients with restrictive, hypertrophic, or congenital cardiomyopathiesFouad Chouairi, Clancy W Mullan, Sounok Sen, et al.Journal of the American Heart Association|December 2, 2021
Impact of Obesity on Heart Transplantation OutcomesFouad Chouairi, Aidan Milner, Sounok Sen, et al.JACC. Heart Failure|February 10, 2020
Real World Use of Hypertonic Saline in Refractory Acute Decompensated Heart Failure: A U.S. Center's ExperienceMatthew Griffin, Aaron Soufer, Erden Goljo, et al.European Heart Journal|March 26, 2021
Clinical characteristics and outcomes in childhood-onset hypertrophic cardiomyopathyNicholas A Marston, Larry Han, Iacopo Olivotto, et al.Circulation|May 16, 2020
Empagliflozin in Heart Failure: Diuretic and Cardiorenal EffectsMatthew Griffin, Veena S Rao, Juan Ivey-Miranda, et al.European Heart Journal|September 7, 2021
Worldwide differences in primary prevention implantable cardioverter defibrillator utilization and outcomes in hypertrophic cardiomyopathyVictor Nauffal, Peter Marstrand, Larry Han, et al.Circulation|October 10, 2018
Genotype and Lifetime Burden of Disease in Hypertrophic Cardiomyopathy: Insights from the Sarcomeric Human Cardiomyopathy Registry (SHaRe)Carolyn Y Ho, Sharlene M Day, Euan A Ashley, et al.Circulation. Genomic and Precision Medicine|December 7, 2020
Associations Between Female Sex, Sarcomere Variants, and Clinical Outcomes in Hypertrophic CardiomyopathyNeal K Lakdawala, Iacopo Olivotto, Sharlene M Day, et al.Journal of the American College of Cardiology|May 30, 2020
Evaluation of Mavacamten in Symptomatic Patients With Nonobstructive Hypertrophic CardiomyopathyCarolyn Y Ho, Matthew E Mealiffe, Richard G Bach, et al.Pageof 8